Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis

被引:64
作者
Aouiss, A. [1 ]
Idrissi, D. Anka [1 ]
Kabine, M. [1 ]
Zaid, Y. [2 ]
机构
[1] Univ Hassan 2, Fac Sci Ain Chock, Dept Biol, Lab Hlth & Environm, Casablanca, Morocco
[2] Montreal Heart Inst, Lab Thrombosis & Hemostasis, Montreal, PQ H1T 1C8, Canada
关键词
Proliferative retinopathy; CD40; CD40L; IL-1; Platelets; OXYGEN-INDUCED RETINOPATHY; CD40; LIGAND; DIABETIC COMPLICATIONS; ENDOTHELIAL-CELLS; ANIMAL-MODELS; IN-VIVO; RETINAL NEOVASCULARIZATION; INTRAVITREAL BEVACIZUMAB; ERYTHROPOIETIN PROTECTS; ALPHA-5-BETA-1; INTEGRIN;
D O I
10.1016/j.retram.2019.01.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Diabetic retinopathy (DR) and retinopathy of prematurity (ROP) present two examples of proliferative retinopathy, characterized by the same stages of progression; ischemia of the retinal vessels, leads to hypoxia and to correct the problem there is the setting up of uncontrolled angiogenesis, which subsequently causes blindness or even detachment of the retina. The difference is the following; that DR initiated by the metabolic complications that are due to hyperglycemia, and ROP is induced by overexposure of the neonatal retina to oxygen. In this review, we will demonstrate the physiopathological mechanism of the two forms of proliferative retinopathy DR and ROP, in particular the role of the CD40/CD40L axis and IL-1 on vascular complications and onset of inflammation of the retina, the implications of their effects on the onset of pathogenic angiogenesis, thus understanding the link between platelets and retinal ischemia. In addition, what are the therapeutic targets that could slow its progression? (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:62 / 71
页数:10
相关论文
共 156 条
[1]
Membrane Ballooning in Aggregated Platelets is Synchronised and Mediates a Surge in Microvesiculation [J].
Agbani, Ejaife O. ;
Williams, Christopher M. ;
Hers, Ingeborg ;
Poole, Alastair W. .
SCIENTIFIC REPORTS, 2017, 7
[2]
The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients [J].
Akdogan, Muberra ;
Ustundag-Budak, Yasemin ;
Huysal, Kagan .
CLINICAL OPHTHALMOLOGY, 2016, 10 :1797-1801
[3]
Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease [J].
André, P ;
Nannizzi-Alaimo, L ;
Prasad, SK ;
Phillips, DR .
CIRCULATION, 2002, 106 (08) :896-899
[4]
CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[5]
Mechanisms of Disease Diabetic Retinopathy [J].
Antonetti, David A. ;
Klein, Ronald ;
Gardner, Thomas W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) :1227-1239
[6]
The CD40/CD40 Ligand System Linking Inflammation With Atherothrombosis [J].
Antoniades, Charalambos ;
Bakogiannis, Constantinos ;
Tousoulis, Dimitris ;
Antonopoulos, Alexios S. ;
Stefanadis, Christodoulos .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (08) :669-677
[7]
Bowman Lecture 1998 - Diabetic retinopathy: some cellular, molecular and therapeutic considerations [J].
Archer, DB .
EYE, 1999, 13 (4) :497-523
[8]
Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment [J].
Avery, Robert L. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (03) :352-354
[9]
Babu E, 2004, Indian J Pathol Microbiol, V47, P202
[10]
Banno K, 2017, PEDIAT RES